Andrea has a commercial education with focus on finance and office management. She worked more than 10 years as office manager for the Confederation of the German Trade Unions /Police Trade Union (DGB/ GdP) in Munich.
During her time as family manager of 2 children, she worked self-employed in her own office for several Munich companies. She startet at Scintomics in 2010, as assistant to the General Manager. Since July 2019 she is CEO of ATT and Scintomics.
Saskia wrote her diploma thesis at the ETH Zurich on surgery simulators, and graduated from Technical University Munich (TUM) with a master’s degree in mechanical engineering. She was involved in an Actinium-225 Project between TUM and Actinium Pharmaceuticals Inc. (USA), where she was responsible for the powder target process development, and worked as a development engineer at a radiopharmaceutical company in Munich on the automation of isotope production and the development of an injector for Re-188 Percutanous Transluminal Angioplasty. Saskia joint SCINTOMICS in 2008, took over the position of the operational manager in May 2010 and became CEO in 2014.
Dorothea has worked for over 30 years in diverse private medical practices (general medicine, paediatric medicine and radiology) and pharmaceutical companies. She gained extensive experience in the QC on transdermal therpeutic systems in a german pharmaceutical company and in the GMP production of pharmaceuticals in a japanese pharmaceutical company. In June 2015 she became CEO with main responsibility for accounting and human resoureces. She is married with Hans-J. Wester, founder of SCINTOMICS.
At SCINTOMICS and att/Scintomics, 2/3 of the employees are women, and 100% of senior management positions are occupied by women.